Brainsway Dtms denied for failing step therapy by Humana?
Step-therapy denials usually flip when the appeal documents that prior alternatives were tried and failed, or were contraindicated, or aren't safe for the patient.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Humana typically requires
Humana's specific coverage criteria for brainsway dtms are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Humana angle on Brainsway Dtms
## Why Humana May Require Step Therapy Before BrainsWay Deep TMS
Step therapy—sometimes called "fail-first"—means Humana requires documentation that the patient has tried and failed one or more specified prior treatments before it will authorize BrainsWay Deep TMS. For a psychiatric neuromodulation device, step therapy typically requires evidence of prior pharmacological treatment failures and, in some cases, psychotherapy. If documentation of prior treatment steps is incomplete or not clearly mapped to Humana's criteria, the PA will be denied even if the patient has clinically failed prior therapies.
Step-therapy denials are among the most commonly overturned on appeal because patients have often already completed the required steps—the issue is documentation, not clinical history.
## Federal Appeal Framework
- ACA §2719 / External Review: Available within approximately 4 months (180 days) of denial for most non-grandfathered plans. Expedited review (72-hour turnaround) applies when clinical urgency exists or ongoing treatment is at risk of interruption.
- ERISA §503: Entitles you to the specific step criteria Humana applied, all clinical guidelines referenced, and a full-and-fair review including the right to submit supplemental documentation.
- State step-therapy laws: Many states have enacted step-therapy reform laws that limit insurers' ability to require additional steps when a patient has already failed equivalent treatments or when step therapy would be clinically contraindicated. Check whether your state's law applies to your plan type.
## Appeal Process and Timeline
1. Request Humana's step-therapy criteria in full — the denial letter or the published coverage policy must specify which prior treatments are required and what constitutes an adequate trial. 2. Reconstruct the complete treatment history — work with the prescriber to compile records for every prior treatment attempt, including start/end dates, doses tried, duration, and the reason for discontinuation or documented inadequate response. 3. Internal appeal — submit the complete step history with a prescriber letter mapping each step to Humana's criteria. Standard review is up to 30 days; urgent is 72 hours. 4. External review — if internal appeal is denied, independent reviewers evaluate whether the step criteria were reasonably applied.
## Documentation to Gather
- Complete prior treatment history: A chronological list of all prior treatments for this condition with dates, documented response, and reason for discontinuation or failure.
- Pharmacy records: Dispense records corroborating medication trials.
- Prescriber medical-necessity letter: Maps each of Humana's required steps to the patient's documented history; explains any steps that could not be completed due to clinical contraindications or tolerability.
- Diagnosis and current severity: Chart documentation showing the condition remains active and inadequately controlled despite prior treatment.
- Step-therapy exception basis (if applicable): Clinical documentation supporting a step-therapy exception (e.g., prior step is contraindicated, or equivalent treatment was completed under a prior plan).
## Criteria-Mapping Structure
Obtain Humana's current Deep TMS coverage policy. For each required step:
| Humana Step Requirement | Patient's Documented History | |---|---| | Step 1: [treatment category per policy] | [Treatment name, dates, outcome from chart] | | Step 2: [treatment category per policy] | [Treatment name, dates, outcome from chart] | | Additional steps as specified | [Corresponding chart documentation] | | Exception basis (if applicable) | [Clinical rationale with supporting notes] |
A thorough, dated, criterion-by-criterion response is the most effective step-therapy appeal. Gaps in documentation—not gaps in treatment history—are the most common reason these appeals fail at the internal stage.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →